Valsartan Tablet
Product Images NDC 50090-5191

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 50090-5191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure01 (Fig01)

This appears to be a data table indicating subgroups of patients in a clinical trial comparing the effectiveness of Valsartan versus Captopril. The subgroups include patients of different ages, genders, ethnicities, nationalities, and use of beta-blockers. The table also shows the percentage of patients in each subgroup and the favorable outcomes for Valsartan versus Captopril with regards to blood pressure medication effectiveness.*

FDA Label Image

Label Image (Lbl500905191)

FDA Label Image

Structuralformula (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.